Molecular / Targeted Therapy

Molecular targets for cancer therapies are drugs that target specific molecular structures involved in tumorigenesis. Contrary to chemotherapy, which kills both healthy, non-cancerous, and cancer cells simultaneously, targeted therapies are far more precise and potentially more effective, and less invasive in cancer treatment. Most targeted therapies are small-molecule drugs that act on targets found inside the cell (usually protein tyrosine kinases) or monoclonal antibodies directed against tumor-specific proteins on the cell surface. Molecular targeted therapy will help you to recover in either of the following ways:

• Destroy cancer cells by assisting the immune system.
• Ensure that cancer cells do not grow.
• Signals that are responsible for forming blood vessels are stopped.
• Infuse cancer cells with substances that kill them.
• The extent of the cancer cell damage is such that the cells will die.
• Stop the growth of cancer by starving it of hormones.

These molecule-deliver molecules deliver drugs directly into or onto cancer cells to damage them.

These disrupt normal cell functions, so the cancer cells die.

These disrupt cell signals so that they change the actions of the cancer cell.